Mallinckrodt Pharmaceuticals Senior Accountant (St. Louis MO) in St. Louis, Missouri
Senior Accountant (St. Louis MO)
JR000009189 Senior Accountant (St. Louis MO) (Open)
MKG-Hazelwood, MO (675) - USA037
St. Louis, MO
SUMMARY OF POSITION
This position is a key contributor to the timely and accurate completion of the company’s monthly, quarterly and annual global financial close, consolidation and reporting process. This position is responsible for completing/reviewing various operational reports submitted by the regional shared service sites. This position interacts with a wide variety of individuals within the organization.
Perform monthly reviews of operating reports prepared by various operating units finance personnel
Completion of monthly, quarterly and annual financial close requirements.
Prepare journal entries and manage post-close entry process.
Account for various corporate assets and liabilities.
Prepare journal entries for intercompany accounting and related reconciliations.
Prepare and communicate close calendar.
Contribute to the completion and review of monthly and quarterly year-to-date balance sheet fluctuation analyses.
Prepare government reports and ad hoc financial information requests.
Prepare foreign exchange rates used for company-wide financial needs.
Work with the Hyperion administration team to implement metadata changes needed for reporting and business needs.
Prepare various reports, analyses and schedules for internal and external auditors.
Bachelor’s degree in Accounting
4 or more years of relevant accounting experience, with a combination of industry and public accounting experience preferred
Demonstrates proficiency in applying accounting expertise; responds positively to changes in business processes; effective oral and written communication skills; ability to take initiative; ability to plan, organize and prioritize responsibilities; excellent PC skills
Experience with Hyperion reporting and SAP general ledger systems preferred
Normal office conditions
Mallinckrodt is a global specialty pharmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products. Areas of focus include therapeutic drugs for autoimmune and rare disease specialty areas like neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal respiratory critical care therapies; and analgesics and central nervous system drugs. The company's core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. The company's Specialty Brands segment includes branded medicines; its Specialty Generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing.
To learn more about Mallinckrodt, visit www.mallinckrodt.com.
Mallinckrodt Pharmaceuticals (“the Company”) maintains a continuing policy of non-discrimination in employment. The Company is an equal opportunity employer and complies with all applicable laws prohibiting discrimination based upon age, ancestry, color, religious creed (including religious dress and grooming practices), disability (mental and physical), marital status, medical condition, genetic information, military and veteran status, national origin (including language use restrictions), political activities or affiliation, race, sex (including pregnancy, child birth, breastfeeding and medical conditions related to pregnancy, child birth or breastfeeding), gender, gender identity and gender expression, sexual orientation, as well as any other category protected by law. Furthermore, it is our policy to provide equal opportunity to individuals with disabilities and protected veterans in all phases of the employment process and in compliance with applicable federal, state, and local laws and regulations on every location in which the company has facilities. This policy of non-discrimination shall include, but not be limited to, the following employment decisions and practices: recruiting, hiring; promotions; demotions or transfers; layoffs; recalls; terminations; rates of pay or other forms of compensation; selection for training, including apprenticeship; and recruitment or recruitment advertising.
Mallinckrodt Pharmaceuticals is required to report certain payments or transfers of value (such as expense reimbursement, meals, transportation) made to U.S.-licensed healthcare professionals in compliance with the federal Physician Payment Sunshine Act (i.e. Open Payments) and certain state laws.